BackOncocyte Overview

Oncocyte Cost of Revenue

Cost of Revenue analysis for OCX.

Quarterly Cost of Revenue

$17000.00
↓ 97.91% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$961000.00
↓ 33.4% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin